Peptaibol Analogs Show Potent Antibacterial Activity against Multidrug Resistant Opportunistic Pathogens
International Journal of Molecular Sciences · 28.04.2023 · 24 (9) · 7997
DOI: 10.3390/ijms24097997 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.04.2023. Verfasst von Chiara Dalla Torre und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, University of Padova, Via Marzolo 1, I-35131 Padova, Italy. Hauptthemen laut MEDLINE: Peptaibols, Acinetobacter baumannii. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry for University and Research.
Abstract (Originalsprache)
New classes of antibacterial drugs are urgently needed to address the global issue of antibiotic resistance. In this context, peptaibols are promising membrane-active peptides since they are not involved in innate immunity and their antimicrobial activity does not involve specific cellular targets, therefore reducing the chance of bacterial resistance development. Trichogin GA IV is a nonhemolytic, natural, short-length peptaibol active against Gram-positive bacteria and resistant to proteolysis. In this work, we report on the antibacterial activity of cationic trichogin analogs. Several peptides appear non-hemolytic and strongly active against many clinically relevant bacterial species, including antibiotic-resistant clinical isolates, such as Staphylococcus aureus, Acinetobacter baumannii, and extensively drug-resistant Pseudomonas aeruginosa, against which there are only a limited number of antibiotics under development. Our results further highlight how the modification of natural peptides is a valuable strategy for obtaining improved antibacterial agents with potential therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, University of Padova, Via Marzolo 1, I-35131 Padova, Italy.
- Dipartimento di Biotecnologie Mediche, University of Siena, Viale Bracci 16, I-53100 Siena, Italy.
- Lead Discovery Siena s.r.l., Via Fiorentina 1, I-53100 Siena, Italy.
- Laboratoire de Bactériologie Moléculaire, Centre d'Ingénierie des Protéines-UR InBioS, University of Liège, Allée du Six Août 11, B-4000 Liège, Belgium.
ORCID-Profile: Filomena Sannio, Jean-Denis Docquier, Marta De Zotti
Förderung
- Italian Ministry for University and Research
Zitieren
APA
Dalla Torre, C., Sannio, F., Battistella, M., Docquier, J. D., & De Zotti, M. (2023). Peptaibol Analogs Show Potent Antibacterial Activity against Multidrug Resistant Opportunistic Pathogens. International Journal of Molecular Sciences, 24(9), 7997. https://doi.org/10.3390/ijms24097997
Vancouver
Dalla Torre C, Sannio F, Battistella M, Docquier JD, De Zotti M. Peptaibol Analogs Show Potent Antibacterial Activity against Multidrug Resistant Opportunistic Pathogens. International Journal of Molecular Sciences. 2023;24(9):7997. doi:10.3390/ijms24097997
BibTeX
@article{DallaTorre2023,
author = {Dalla Torre, Chiara and Sannio, Filomena and Battistella, Mattia and Docquier, Jean-Denis and De Zotti, Marta},
title = {Peptaibol Analogs Show Potent Antibacterial Activity against Multidrug Resistant Opportunistic Pathogens},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {9},
pages = {7997},
doi = {10.3390/ijms24097997}
}
EUVIMED